Equal efficacy of topical tacrolimus and clobetasone butyrate in pemphigus foliaceus [8]

International Journal of Dermatology

Volumn 45, Issue 11, 2006, Pages 1379-

  Cohen, Stuart N ^a   Lim, Regina P R ^a   Paul, C Jose ^a   Abdullah, Anthony ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLOBETASONE BUTYRATE; COMPLEMENT COMPONENT C3; CYCLOSPORIN A; DAPSONE; IMMUNOGLOBULIN G; PREDNISOLONE; STEROID; TSUKUBAENOLIDE;

AGED; CASE REPORT; CAUCASIAN; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GINGIVITIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LETHARGY; LETTER; LONG TERM CARE; MAINTENANCE DRUG DOSE; MUSCLE CRAMP; NEUTROPENIA; PEMPHIGUS FOLIACEUS; RASH; SKIN ATROPHY; SKIN BIOPSY; SKIN BURNING SENSATION; SKIN EXAMINATION; TELANGIECTASIA; TREATMENT REFUSAL;

ADMINISTRATION, CUTANEOUS; AGED; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OINTMENTS; PEMPHIGUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 33750632858     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02901.x     Document Type: Letter

References (6)

1. Scott JE, Ahmed AR. The blistering diseases. Med Clin North Am 1998; 82: 1239-1283.
2. Lin M-S, Swartz SJ, Lopez A, et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 1997; 99: 31-40.
3. Grassberger M, Baumruker T, Enz A, et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: In vitro pharmacology. Br J Dermatol 1999; 141: 264-273.
4. Wesselborg S, Fruman DA, Sagoo JK, et al. Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). J Biol Chem 1996; 271: 1274-1277.
5. Ruzicka T, Assmann T, Lebwohl M. Potential future dermatological indications for tacrolimus ointment. Eur J Dermatol 2003; 13: 331-342.
6. Shainhouse T, Eichenfield LF. Long-term safety of tacrolimus ointment in children treated for atopic dermatitis. Expert Opin Drug Saf 2003; 2: 457-465.